p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Oncogene

• Publication date

  1996-10-03

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8875988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor-beta1 modulates p107 function in myeloid cells: correlation with cell cycle progression.

  1996cited by this paper
• v-Abl activates c-myc transcription through the E2F site

  1995cited by this paper
• A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

  1995cited by this paper
• Proto-oncogenic properties of the DP family of proteins.

  1995cited by this paper
• Nuclear localization of v-Abl leads to complex formation with cyclic AMP response element (CRE)-binding protein and transactivation through CRE motifs

  1995cited by this paper
• Activation of c-myc expression by c-Abl is independent of both the DNA binding function of c-Abl and the c-myc EP site.

  1994cited by this paper
• The cell cycle and the retinoblastoma protein family

  1994cited by this paper
• Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.

  1994cited by this paper
• Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.

  1994cited by this paper
• E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.

  1994cited by this paper
• Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins

  1994cited by this paper
• C-myc gene chromatin of estrogen receptor positive and negative breast cancer cells.

  1993cited by this paper
• The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.

  1993cited by this paper
• A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.

  1993cited by this paper
• Transforming growth factor beta 1 (TGF-beta 1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-beta 1-growth stimulated colon carcinoma cells.

  1992cited by this paper
• Retinoblastoma protein switches the E2F site from positive to negative element

  1992cited by this paper
• Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.

  1992cited by this paper
• The retinoblastoma gene product regulates Sp1-mediated transcription

  1992cited by this paper
• Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.

  1992cited by this paper
• E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

  1992cited by this paper
• Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.

  1992cited by this paper
• SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

  1991cited by this paper
• Negative regulation of human c-fos expression by the retinoblastoma gene product

  1991cited by this paper
• Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.

  1991cited by this paper
• Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function

  1991cited by this paper
• A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis.

  1991cited by this paper
• Oncogenes and signal transduction.

  1991cited by this paper
• Differential expression of transforming growth factor-beta 1 (TGF-beta 1) receptors in murine myeloid cell lines transformed with oncogenes. Correlation with differential growth inhibition by TGF-beta 1.

  1991cited by this paper
• Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.

  1990cited by this paper
• TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

  1990cited by this paper
• Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex

  1990cited by this paper
• New light on Myc and Myb. Part I. Myc.

  1990cited by this paper
• TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

  1990cited by this paper
• Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.

  1990cited by this paper
• Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.

  1989cited by this paper
• E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

  1989cited by this paper
• TGF-beta inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events.

  1988cited by this paper
• Lectins modulate the internalization of recombinant interferon-alpha A and the induction of 2',5'-oligo(A) synthetase.

  1988cited by this paper
• Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro.

  1988cited by this paper
• Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta

  1988cited by this paper
• The molecular genetics of cancer.

  1987cited by this paper
• Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes.

  1987cited by this paper
• Transforming growth factor type beta regulation of actin mRNA.

  1986cited by this paper
• Growth factors and cancer.

  1986cited by this paper
• Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

  1986cited by this paper
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

  1985cited by this paper
• Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma.

  1984cited by this paper
• Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

  1984cited by this paper
• Biologic properties of factor-independent nonadherent hematopoietic and adherent preadipocyte cell lines derived from continuous bone marrow culture.

  1984cited by this paper
• The mouse c-abl locus: molecular cloning and characterization.

  1984cited by this paper
• Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.

  1983cited by this paper
• Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

  1983cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper
• Transfection of Fibroblasts by Cloned Abelson Murine Leukemia Virus DNA and Recovery of Transmissible Virus by Recombination with Helper Virus

  1982cited by this paper
• Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA.

  1981cited by this paper
• Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation

  1980cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Lymphosarcoma: virus-induced thymic-independent disease in mice.

  1970cited by this paper

• E2F1 transcription factor and its impact on growth factor and cytokine signaling.

  2016cites this paper
• c-myc Is a Downstream Target of the Smad Pathway* 210

  2002cites this paper
• The p120-v-Abl Protein Interacts with E2F-1 and Regulates E2F-1 Transcriptional Activity*

  1997cites this paper